US2007298436A1PendingUtilityA1

Changeable machine readable assaying indicia

Assignee: LAPPE MURRAYPriority: Feb 14, 1997Filed: Aug 27, 2007Published: Dec 27, 2007
Est. expiryFeb 14, 2017(expired)· nominal 20-yr term from priority
Inventors:Murray Lappe
B01L 2300/069G01N 33/528B01L 3/502715B01L 2300/042B01L 2300/0832B01L 2400/0406Y10T436/25B01L 3/545Y10T436/13B01L 2200/141G01N 35/00871G16H 40/63G01N 33/54366B01L 2200/0605B01L 2400/0683B01L 2400/0478Y10T436/12B01L 2300/0663B01L 3/502B01L 2300/021G06K 19/10B01L 2300/047G01N 33/94B01L 2300/025B01L 2300/046B01L 2300/0825G16H 10/40G06Q 30/018G06K 2019/06253G06V 40/30G16H 10/60G16H 40/67
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A machine readable assaying system comprising a test card having machine readable assaying means. A plurality of individual analysis strips, each strip comprising antibodies and/or reagents capable of indicating the positive presence of distinct illicit substances form a pattern of elements including one or more fixed strips and one or more blank regions. The detection of the presence of a particular substance or drug will result in one or more of the analysis strips changing from a first (light reflective) color to a second darker (light absorbent) color. The pattern of analysis strips, fixed strips and blank regions may be provided to encode one or more characters/digits of information. By the inclusion of the analysis strips with the plurality of fixed strips and blank regions, the detection of one or more illicit substances may alter the overall pattern of fixed and test strips and blank regions, and hence cause the encoded information represented thereby to be altered. Accordingly, the particular pattern of bars and spaces that result from an exposure the physiological fluids of a donor is contemplated to produce a distinct machine readable indicia. The transformation which occurs on the test card will be uninterpretable by the administrator of the test, thus preserving the anonymity and privacy of the tested individual.

Claims

exact text as granted — not AI-modified
1 . A method of carrying out a test to detect for the presence or absence of a target substance in a human donor-derived physiological sample, said method comprising the steps of: 
 providing: (1) a test surface adapted to contact said sample and having at least one machine-readable indicium thereon, said indicium having an initial state and being capable of changing to an altered state in response to contact with said sample; and (2) a scanning unit capable of scanning said machine-readable indicium on said surface, said scanning unit including a programmed processor and a memory unit;    contacting said test surface with said sample; and    after said contacting step, using said scanning unit to scan said at least one indicium, and operating said processor to generate test data as a result of said scan,    said indicium being machine-readable only and not human interpretable in the absence of said machine reading.    
   
   
       2 . The method of  claim 1 , including the step of transmitting said test data to data storage separate from said scanning unit.  
   
   
       3 . The method of  claim 2 , said transmitting step comprising the step of transmitting the test data over a communications link.  
   
   
       4 . The method of  claim 1 , wherein said sample is a fluid sample.  
   
   
       5 . The method of  claim 1 , said surface having a plurality of machine-readable indicia thereon.  
   
   
       6 . The method of  claim 1 , said sample being a urine sample.

Join the waitlist — get patent alerts

Track US2007298436A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.